To shorten the development and prototyping period. Active in a wide range of applications such as implants and scaffolds.
"BioDegmer Filament" is a 3D printer filament with excellent biocompatibility and biodegradability. It can be used in a wide range of applications in the medical field, such as implants and scaffolds for cell and tissue regeneration. By creating 3D models, it allows for physical examination of the actual models, which is expected to shorten the time required for strength and precision verification, as well as testing and validation. 【Features】 ■ For research and development in the medical field ■ Filament diameter: 1.75mm ■ Consultation available for prototyping and evaluation of printed products, structural design, and 3D data creation *For more details, please refer to the materials. Feel free to contact us with any inquiries.
Inquire About This Product
basic information
【Lineup (Prototype Achievements)】 - Glycolic acid / L-lactic acid copolymer (PGLA) - Poly-L-lactic acid (PLLA) - Poly-ε-caprolactone (PCL) - L-lactic acid / ε-caprolactone copolymer (LCL) - Poly-p-dioxanone (PDO)
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the materials. Feel free to contact us as well.
catalog（1）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.
